BlackRock’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-894,894
| Closed | -$1.98M | – | 5569 |
|
|
2023
Q2 | $1.98M | Sell |
894,894
-172,117
| -16% | -$357K | ﹤0.01% | 4055 |
|
|
2023
Q1 | $2.71M | Sell |
1,067,011
-111,780
| -9% | -$221K | ﹤0.01% | 3911 |
|
|
2022
Q4 | $2.2M | Sell |
1,178,791
-24,655
| -2% | -$61.5K | ﹤0.01% | 4102 |
|
|
2022
Q3 | $3.09M | Buy |
1,203,446
+334,222
| +38% | +$831K | ﹤0.01% | 3969 |
|
|
2022
Q2 | $1.68M | Sell |
869,224
-2,071,289
| -70% | -$4.52M | ﹤0.01% | 4322 |
|
|
2022
Q1 | $8.73M | Sell |
2,940,513
-37,167
| -1% | -$140K | ﹤0.01% | 3648 |
|
|
2021
Q4 | $13.4M | Buy |
2,977,680
+60,540
| +2% | +$287K | ﹤0.01% | 3502 |
|
|
2021
Q3 | $14.2M | Buy |
2,917,140
+19,820
| +0.7% | +$109K | ﹤0.01% | 3500 |
|
|
2021
Q2 | $19.8M | Sell |
2,897,320
-581,120
| -17% | -$4.7M | ﹤0.01% | 3315 |
|
|
2021
Q1 | $24.6M | Buy |
3,478,440
+31,111
| +0.9% | +$224K | ﹤0.01% | 3072 |
|
|
2020
Q4 | $21.6M | Buy |
3,447,329
+416,481
| +14% | +$2.45M | ﹤0.01% | 2967 |
|
|
2020
Q3 | $16.4M | Buy |
3,030,848
+269,112
| +10% | +$1.33M | ﹤0.01% | 2971 |
|
|
2020
Q2 | $14.4M | Buy |
2,761,736
+352,887
| +15% | +$1.57M | ﹤0.01% | 2983 |
|
|
2020
Q1 | $7.59M | Buy |
2,408,849
+84,937
| +4% | +$313K | ﹤0.01% | 3135 |
|
|
2019
Q4 | $9.37M | Sell |
2,323,912
-322,988
| -12% | -$1.12M | ﹤0.01% | 3280 |
|
|
2019
Q3 | $11.4M | Buy |
2,646,900
+92,108
| +4% | +$368K | ﹤0.01% | 3142 |
|
|
2019
Q2 | $10.2M | Sell |
2,554,792
-52,694
| -2% | -$251K | ﹤0.01% | 3247 |
|
|
2019
Q1 | $14M | Sell |
2,607,486
-68,946
| -3% | -$445K | ﹤0.01% | 2936 |
|
|
2018
Q4 | $13.7M | Sell |
2,676,432
-722
| -0% | -$5.48K | ﹤0.01% | 2929 |
|
|
2018
Q3 | $26M | Buy |
2,677,154
+93,764
| +4% | +$946K | ﹤0.01% | 2729 |
|
|
2018
Q2 | $26.4M | Buy |
2,583,390
+554,545
| +27% | +$6.28M | ﹤0.01% | 2707 |
|
|
2018
Q1 | $26.4M | Buy |
2,028,845
+125,194
| +7% | +$1.86M | ﹤0.01% | 2616 |
|
|
2017
Q4 | $34.1M | Sell |
1,903,651
-26,062
| -1% | -$544K | ﹤0.01% | 2494 |
|
|
2017
Q3 | $48.4M | Buy |
1,929,713
+37,266
| +2% | +$867K | ﹤0.01% | 2316 |
|
|
2017
Q2 | $45.6M | Buy |
1,892,447
+388,605
| +26% | +$8.59M | ﹤0.01% | 2311 |
|
|
2017
Q1 | $28.9M | Buy |
1,503,842
+1,501,785
| +73,009% | +$23.7M | ﹤0.01% | 2534 |
|
|
2016
Q4 | $31K | Buy |
2,057
+683
| +50% | +$8.87K | ﹤0.01% | 3125 |
|
|
2016
Q3 | $18K | Hold |
1,374
| – | – | ﹤0.01% | 3312 |
|
|
2016
Q2 | $19K | Buy |
1,374
+650
| +90% | +$9.57K | ﹤0.01% | 3284 |
|
|
2016
Q1 | $11K | Buy |
724
+434
| +150% | +$6.64K | ﹤0.01% | 3126 |
|
|
2015
Q4 | $6K | Hold |
290
| – | – | ﹤0.01% | 3103 |
|
|
2015
Q3 | $6K | Hold |
290
| – | – | ﹤0.01% | 2960 |
|
|
2015
Q2 | $7K | Buy |
+290
| New | +$8.23K | ﹤0.01% | 3010 |
|
BlackRock's PRTK Position: Q3 2023 in Review
BlackRock sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 894,894 shares — an estimated $1.98M sold.
BlackRock first reported a position in PRTK in Q2 2015 and held it in 33 quarters. The position peaked at $48.4M in Q3 2017. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.
- BlackRock reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
- BlackRock sold 894,894 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $1.98M.
- BlackRock first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2015 and held it in 33 quarters.
- BlackRock's Paratek Pharmaceuticals, Inc. position peaked at $48.4M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.
Based on BlackRock's 13F filing for Q3 2023, filed 13 Nov 2023.